http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2459817-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d96e66cd6618245934bfd25766eb17cc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-22
filingDate 2007-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c34c4f3f13f752aa9362f44f4d1dbc5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_971c3dabd7b5537547f2bb398ab0d7cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46fbb7b96043814a2b73fa62261bdb4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfdae5c15add3e5af2c3bdcec1810adb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c45d5bfcfe238e769b48fb2109c82de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_504a6512683aa84226bb5c488daa3b86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa0a17b08f71b98531b1b9939f9eb475
publicationDate 2012-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2459817-C2
titleOfInvention Substituted chromanol derivatives and method for preparing them
abstract FIELD: medicine, pharmaceutics. n SUBSTANCE: present invention refers to a compound of formula (I) wherein A, D, R 1 , R 2 , R 3 , R 4 and R 5 are those as presented in cl.1 of the patent claim, as well as to its salt. What is also described is a method for preparing the compound of formula (I). n EFFECT: preparing new substituted chromanol derivatives exhibiting improved pharmacological activity with respect to cardiovascular diseases. n 4 cl, 43 ex, 5 tbl
priorityDate 2006-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0818197-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9914174-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424652243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424652246
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58002996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58002963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424652250
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58002935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58002966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466167036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466164492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413641120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58002986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58003026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58003005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413641146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413641518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58003007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466164495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466167030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424652234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466167035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424652237

Total number of triples: 54.